Evaluation of antitumor effects of two vine stalk oligomers of resveratrol on a panel of lymphoid and myeloid cell lines: Comparison with resveratrol

被引:47
作者
Barjot, Catherine [2 ]
Tournaire, Magali [2 ]
Castagnino, Chantal [3 ]
Vigor, Claire [1 ]
Vercauteren, Joseph [1 ]
Rossi, Jean-Francois [2 ,4 ]
机构
[1] Univ Montpellier I, Fac Pharm, Lab Pharmacognosy, F-34093 Montpellier, France
[2] CellGen SA, INSERM, F-34197 Montpellier, France
[3] Polyphenols R&D, SARL, CEEI, F-34830 Clapiers, France
[4] Lapeyronie Hosp, Dept Hematol Oncol, F-34295 Montpellier, France
关键词
B cell malignancies; multiple myeloma; resveratrol; epsilon-viniferin; miyabenol C;
D O I
10.1016/j.lfs.2007.08.047
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study aims to evaluate and compare the antiproliferative and proapoptotic effects of resveratrol (trans-3,4',5-trihydoxystilbene) with two of its naturally occurring oligomers, epsilon-viniferin (a dimer) and miyabenol C (a trimer). Proliferation assays performed on myeloid and lymphoid cell lines show that the three compounds inhibit cell growth of all cell types tested, with miyabenol C being the most efficient (IC50 ranging from 10.8 to 29.4 mu M). Further analysis performed on the multiple myeloma cell line U266 shows that all compounds modify cell cycle distribution probably via actions on different targets. Whereas cells treated with resveratrol accumulate in S phase, cells treated with epsilon-viniferin and miyabenol C accumulate in G2/M and G0/G1, respectively. Miyabenol C is also the most efficient at inducing cell death in U266 cells. All compounds induce apoptosis of U266 cells via mechanisms entirely dependent on caspase activation and associated with mitochondrial membrane potential disruption. Compounds do not act directly on the mitochondrial membrane, but could induce activation of upstream caspases such as caspase 8 and/or caspase 2, depending on the compound. In no case did upstream caspase 8 activation involve Fas/FasL interaction. Taken together, these results show that e-viniferin and, more importantly, miyabenol C represent potent antitumor agents that require further investigation, either alone or in combination with resveratrol. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1565 / 1574
页数:10
相关论文
共 41 条
[1]  
Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
[2]   Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells [J].
Bernhard, D ;
Tinhofer, I ;
Tonko, M ;
Hübl, H ;
Ausserlechner, MJ ;
Greil, R ;
Kofler, R ;
Csordas, A .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (09) :834-842
[3]   Comparative antiproliferative and apoptotic effects of resveratrol, ε-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes [J].
Billard, C ;
Izard, JC ;
Roman, V ;
Kern, C ;
Mathiot, C ;
Mentz, F ;
Kolb, JP .
LEUKEMIA & LYMPHOMA, 2002, 43 (10) :1991-2002
[4]   Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoclast differentiation [J].
Boissy, P ;
Andersen, TL ;
Abdallah, BM ;
Kassem, M ;
Plesner, T ;
Delaissé, JM .
CANCER RESEARCH, 2005, 65 (21) :9943-9952
[5]   SIMULTANEOUS MEASUREMENT OF DNA CONTENT AND CELL-SURFACE IMMUNOFLUORESCENCE OF HUMAN BONE-MARROW CELLS USING A SINGLE LASER FLOW CYTOMETER [J].
BRONS, PPT ;
PENNINGS, AHM ;
HAANEN, C ;
WESSELS, HMC ;
BOEZEMAN, JBM .
CYTOMETRY, 1990, 11 (07) :837-844
[6]   Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside [J].
Bruno, B ;
Giaccone, L ;
Rotta, M ;
Anderson, K ;
Boccadoro, M .
LEUKEMIA, 2005, 19 (10) :1729-1738
[7]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[8]   Perspectives for combination therapy to overcome drug-resistant multiple myeloma [J].
Catley, L ;
Tai, YT ;
Chauhan, D ;
Anderson, KC .
DRUG RESISTANCE UPDATES, 2005, 8 (04) :205-218
[9]  
Chauhan D, 2000, J BIOL CHEM, V275, P27845
[10]  
Clément MV, 1998, BLOOD, V92, P996